Welcome to Michigan Psychedelic Center (M-PsyC)

A rigorous, multidisciplinary team focused on psychedelic neuroscience and therapy.

The Michigan Psychedelic Center (M-PsyC) launched at the University of Michigan in 2022 with a mission to advance multidisciplinary education, research, therapy, and community engagement related to psychedelics.
University of Michigan partners:
  • Center for Consciousness Science
  • Center for Drug Repurposing
  • Chronic Pain & Fatigue Research Center
  • College of Literature, Science, and the Arts
  • College of Pharmacy
  • Law School
  • Life Sciences Institute
  • Medical School
  • Michigan Institute for Clinical and Health Research
  • School of Music, Theater, and Dance
  • School of Nursing
  • School of Public Health
  • School of Social Work

Participate in Our Research: Now Recruiting Subjects 

The Mood Disorders Lab at University of Michigan is now recruiting subjects for COMP006, a multicenter, randomized, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two initial administrations of COMP360 in participants with treatment-resistant depression (TRD). This study is a Phase 3 multisite study with COMPASS Pathways, Ltd. looking into efficacy and safety of synthetic Psilocybin for TRD. Those interested in receiving additional information on the study may contact: 

Our Work

M-PsyC focuses on four areas as related to psychedelic drugs and the psychedelic experience




Community Engagement

M-PsyC featured as Medicine at Michigan cover story

Through research on psychedelics and chronic pain, treatment of depression with ketamine, and a rigorous academic approach to the topic, our researchers and clinicians are seeking nothing short of expanding our understanding of consciousness and improving patient care.